Dr. Malik D. Murtaza, MD

Dr. Murtaza practices at West Tennessee Medical Group Inc in Jackson, Tennessee.

Dr. Murtaza's NPI, 1437605151, was assigned on September 1, 2016. Dr. Murtaza holds Tennessee license 67069.

Dr. Murtaza's primary practice is West Tennessee Medical Group Inc, at 1804 Highway 45th Byp, Jackson, TN 38305 in Madison County. The practice phone is (731) 660-8730.

Dr. Murtaza's primary practice is West Tennessee Medical Group Inc in Jackson, Tennessee. Dr. Murtaza is also affiliated with West Tennessee Healthcare Jackson-Madison County General Hospital. The medical group on file is West Tennessee Medical Group. Dmand AI also links Dr. Murtaza to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Murtaza practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Murtaza's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Murtaza's licenses on file in 2 states: Tennessee and Texas.

CMS data shows 1,372 Medicare services from Dr. Murtaza across 20 procedure codes in 2024, for 564 Medicare patients. Medicare paid $95,105 for them.

CMS counts 564 Medicare patients who saw Dr. Murtaza in 2024. The largest group is 65 to 74, with 224 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Murtaza's median patient age at 64, with 51% women.

In 2024, Dr. Murtaza wrote 893 Medicare Part D claims for 180 patients. 87% of them were for generic drugs. CMS names the drug for 792 of them, across 18 drugs with 11 or more claims each, at $39,475 in total drug cost. In 2023, CMS named 73 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Murtaza for performance year 2024, reported through an alternative payment model (APM). Dr. Murtaza accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 44 procedures of coronary angioplasty and stenting by Dr. Murtaza, more than 80% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Murtaza in 2021. Dr. Murtaza's most frequent co-authors are Purnima Sharma, MD, Purnima Sharma and Byomesh Kumar Tripathi, MD.

CMS Open Payments shows 50 general payments to Dr. Murtaza from 14 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 66% of the total. Edwards Lifesciences Corporation paid the most, $1,555.